Key result
A proposed novel algorithm using high-sensitivity troponin and creatine kinase isoforms aims to rapidly diagnose myocardial infarction within 1-3 hours of symptom onset and differentiate MI types.
A proposed algorithm using cardiac biomarkers like hs-Tn and CK isoforms aims to improve the rapid diagnosis and differentiation of myocardial infarction types, with potential future utility in cerebrovascular events.
Answers are grounded in this paper and cite their sources.
May hasten MI diagnosis if validated; hypothesis-generating and requires prospective trials before any practice change.
We propose a contemporary and novel algorithm using cardiac specific biomarkers for patients presenting with chest pain and other disease states associated with elevated levels of troponin T (TnT) and/or creatine kinase (CK) isoforms. We predict the implementation of this novel algorithm will differentiate between a type-I and type-II myocardial infarction (MI). We summarize advances using high-sensitivity Tn assays (hs-Tn), which include a greater sensitivity for rapid diagnosis of MI within 1-3 hours of symptom onset and is predictive of patient prognosis. We summarize the use of CK isoenzymes as a diagnostic marker for various disease states, determine myocardial infarct size, differentiate MI type, and diagnose myocardial reinfarction. We propose further studies using CK isoforms to define transient ischemic attack (TIA) and cerebrovascular accident (CVA) in order to direct treatments for acute CVA.
No takes yet. Share an insight, caveat, or question.
Miner et al. (2018) conducted a review in Chest pain, myocardial infarction, and cerebrovascular accident. Novel algorithm using cardiac specific biomarkers (TnT and CK isoforms) was evaluated. A proposed novel algorithm using high-sensitivity troponin and creatine kinase isoforms aims to rapidly diagnose myocardial infarction within 1-3 hours of symptom onset and differentiate MI types.
Synapse has enriched 10 related papers. Consider them for comparative context: